We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Original Investigation |

Reappraisal of Central Pancreatectomy:  A 12-Year Single-Center Experience

Yvain Goudard, MD1; Sebastien Gaujoux, MD, PhD1,2,3; Safi Dokmak, MD1; Jérôme Cros, MD, PhD2,3,4; Anne Couvelard, MD, PhD2,3,4; Maxime Palazzo, MD2,3,5; Maxime Ronot, MD2,6; Marie-Pierre Vullierme, MD2,6; Philippe Ruszniewski, MD2,3,5; Jacques Belghiti, MD1,2; Alain Sauvanet, MD1,2
[+] Author Affiliations
1Department of Hepatobiliary and Pancreatic Surgery, Hôpital Beaujon, Assistance Publique–Hôpitaux de Paris, Clichy, France
2Université Paris Diderot, Paris, France
3Centre de Recherche Biomédicale Bichat-Beaujon, Institut National de la Santé et de la Recherche Médicale (INSERM) U773, Paris, France
4Department of Pathology, Hôpital Beaujon, Assistance Publique–Hôpitaux de Paris, Clichy, France
5Department of Gastroenterology, Hôpital Beaujon, Assistance Publique–Hôpitaux de Paris, Clichy, France
6Department of Radiology, Hôpital Beaujon, Assistance Publique–Hôpitaux de Paris, Clichy, France
JAMA Surg. 2014;149(4):356-363. doi:10.1001/jamasurg.2013.4146.
Text Size: A A A
Published online

Importance  Central pancreatectomy, as an alternative to standard resection for benign and low-grade pancreatic neoplasms, has been described in mainly small retrospective series.

Objective  To describe a large single-center experience with central pancreatectomy.

Design, Setting, and Participants  A retrospective case series in a tertiary referral center included 100 consecutive patients undergoing central pancreatectomy with pancreaticogastrostomy from January 1, 2000, to March 1, 2012.

Main Outcomes and Measures  Surgical indications, postoperative morbidity, mortality, and long-term outcomes regarding pancreatic function and recurrence.

Results  Central pancreatectomies were performed mainly for neuroendocrine tumors (35%), intraductal papillary mucinous neoplasms (33%), solid pseudopapillary neoplasms (12%), and mucinous cystadenomas (6%). The postoperative mortality rate was 3% (due to pulmonary embolisms in 2 patients and hemorrhage after pancreatic fistula in 1 patient). Clavien-Dindo III or IV complications occurred in 15% of patients and were due mainly to pancreatic fistula, requiring 10 radiologic drainage procedures, 7 endoscopic procedures, and 6 reoperations overall. After a median follow-up of 36 months, the rates of new-onset exocrine and endocrine insufficiency were 6% and 2%, respectively. Overall, 7 lesions could be considered undertreated, including 3 node-negative R0 microinvasive intraductal papillary mucinous neoplasms (without recurrence at 27, 29, and 34 months) and 4 node-positive neuroendocrine tumors (with 1 hepatic recurrence at 66 months). Among the 25 patients with a doubtful preoperative diagnosis, 9 could be considered overtreated (ie, operated on for benign nonevolutive asymptomatic lesions).

Conclusions and Relevance  Central pancreatectomy is associated with an excellent pancreatic function at the expense of a significant morbidity and a non-nil mortality rate, underestimated by the published literature. The procedure is best indicated for benign or low-grade lesions in young and fit patients who can sustain a significant postoperative morbidity and could benefit from the excellent long-term results.

Figures in this Article

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal


Place holder to copy figure label and caption
Disease-Free Survival

Disease-free survival rates in the 97 patients undergoing central pancreatectomy for benign and low-grade pancreatic neoplasm (Kaplan-Meier survival curve).

Graphic Jump Location




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment


Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 3

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Collections
PubMed Articles
[Cryptosporidiosis of the pancreas]. Vestn Khir Im I I Grek 2014;173(4):92-4.